Table 2.
Clinical features of PASC and POTS patients following COVID-19 infection. Standard deviations are presented in the parentheses. (N/A: not applicable).
| Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC) | Postural Orthostatic Tachycardia Syndrome (POTS) | p Values for t-Test between PASC and POTS | Control | |
|---|---|---|---|---|
| Mean duration of symptoms in months | 21.15 (± 5.15) | 138.83 (± 123.16) | <0.01 | N/A |
| Severity of COVID-19 infection | Mild—11/13 (84.62%) Moderate—2/13 (15.38%) |
N/A | N/A | N/A |
| Fatigue | 13/13 (100%) | 6/6 (100%) | N/A | None |
| Orthostatic intolerance | 13/13 (100%) | 6/6 (100%) | N/A | None |
| Palpitations | 8/13 (61.54%) | 3/6 (50%) | 0.64 | None |
| Shortness of breath | 9/13 (69.23%) | 4/6 (66.67%) | 0.90 | None |
| Chest pain | 3/13 (23.08%) | 0/6 (0%) | 0.20 | None |
| Headache | 5/13 (38.46%) | 3/6 (50%) | 0.64 | None |
| Brain fog | 12/13 (92.30%) | 6/6 (100%) | 0.48 | None |
| Diffuse pain | 7/13 (53.85%) | 2/6 (33.33%) | 0.41 | None |
| Gastrointesstinal symptoms | 9/13 (69.23%) | 3/6 (50%) | 0.42 | None |
| Post-exertional malaise | 11/13 (92.30%) | 6/6 (100%) | 0.48 | None |
| Insomnia | 10/13 (76.92%) | 4/6 (66.67%) | 0.64 | None |
PASC: Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC). POTS: Postural Orthostatic Tachycardia Syndrome.